Theodore P Braun

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 17

Top Venues

Leukemia

Nature communications

Molecular cancer research : MCR

JCO precision oncology

Oregon Health & Science University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Oregon Health & Science University Sep 01 2008 - Jun 01 2012

United States

PHD :: Cell & Developmental Biology

Publications

Sonia N Acharya, Ruth V Nichols, Lauren E Rylaarsdam, Brendan L O'Connell, Theodore P Braun, Andrew C Adey
sciMET-cap: High-throughput single-cell methylation analysis with a reduced sequencing burden. bioRxiv : the preprint server for biology (2023)
William M Yashar, Brittany M Curtiss, Daniel J Coleman, Jake VanCampen, Garth L Kong, Jommel Macaraeg, Joseph Estabrook, Emek Demir, Nicola Long, Daniel Bottomly, Shannon K McWeeney, Jeffrey W Tyner, Brian J Druker, Julia E Maxson, Theodore P Braun
Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia. Molecular cancer research : MCR (2023)
Sarah A Carratt, Garth L Kong, Cody Coblentz, Zachary Schonrock, Lauren Maloney, Benjamin R Weeder, William M Yashar, Rowan Callahan, Hunter Z Blaylock, Colin Coleman, Dan Coleman, Theodore P Braun, Julia E Maxson
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development. Leukemia (2023)
Carl M Post, Theodore P Braun, Ruth B Etzioni, Nima Nabavizadeh
Multicancer Early Detection Tests: An Overview of Early Results From Prospective Clinical Studies and Opportunities for Oncologists. JCO oncology practice (2023)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Mariam Okhovat, Cody Coblentz, Sarah A Carratt, Amy Foley, Zachary Schonrock, Brittany M Curtiss, Kimberly Nevonen, Brett A Davis, Brianna Garcia, Dorian LaTocha, Benjamin R Weeder, Michal R Grzadkowski, Joey C Estabrook, Hannah G Manning, Kevin Watanabe-Smith, Sophia Jeng, Jenny L Smith, Amanda R Leonti, Rhonda E Ries, Shannon K McWeeney, Cristina Di Genua, Roy Drissen, Claus Nerlov, Soheil Meshinchi, Lucia Carbone, Brian J Druker, Julia E Maxson
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia. Nature communications 13 (1) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Brittany M Curtiss, Jake VanCampen, Jommel Macaraeg, Garth L Kong, Akram Taherinasab, Mitsuhiro Tsuchiya, William M Yashar, Yiu H Tsang, Wesley Horton, Daniel J Coleman, Joseph Estabrook, Theresa A Lusardi, Gordon B Mills, Brian J Druker, Julia E Maxson, Theodore P Braun
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia. Leukemia 36 (7) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
William M Yashar, Garth Kong, Jake VanCampen, Brittany M Curtiss, Daniel J Coleman, Lucia Carbone, Galip Gürkan Yardimci, Julia E Maxson, Theodore P Braun
GoPeaks: histone modification peak calling for CUT&Tag. Genome biology 23 (1) (2022)
Aaron M Tsumura, Brian J Druker, Diana Brewer, Richard D Press, Theodore P Braun
BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia. JCO precision oncology 5 (2021)
Theodore P Braun, Cody Coblentz, Brittany M Smith, Daniel J Coleman, Zachary Schonrock, Sarah A Carratt, Rowan L Callahan, Breanna N Maniaci, Brian J Druker, Julia E Maxson
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America 117 (24) (2020)
Theodore P Braun, Mariam Okhovat, Cody Coblentz, Sarah A Carratt, Amy Foley, Zachary Schonrock, Brittany M Smith, Kimberly Nevonen, Brett A Davis, Brianna Garcia, Dorian LaTocha, Benjamin R Weeder, Michal R Grzadkowski, Joey C Estabrook, Hannah G Manning, Kevin Watanabe-Smith, Sophia Jeng, Jenny L Smith, Amanda R Leonti, Rhonda E Ries, Shannon K McWeeney, Cristina Di Genua, Roy Drissen, Claus Nerlov, Soheil Meshinchi, Lucia Carbone, Brian J Druker, Julia E Maxson
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia. Nature communications 10 (1) (2019)

Theodore P Braun.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Theodore P Braun